GMP– tag –
-
RoosterBio and Applied StemCell Announce Strategic Partnership for iPSC-Based Bioprocess Solutions
BioSpace USA Overview RoosterBio and Applied StemCell have announced a strategic partnership aimed at developing and commercializing iPSC-based bioprocess solutions. This collaboration combines Applied StemCell's GMP-compatible iPSC tech... -
RoslinCT and BlueRock Therapeutics Partner to Expand Supply of Clinical-Grade iPSC Lines, Supporting Cell Therapy Development
PharmaSource UK Overview RoslinCT has announced a strategic partnership with BlueRock Therapeutics to expand access to clinical-grade iPSC lines for cell therapy developers. This collaboration integrates BlueRock's high-quality clinical-... -
Catalent and Nanoscope Expand Supply Partnership for Commercialization of Optogenetic Gene Therapy MCO-010 for Retinal Degenerative Diseases
LucidQuest Ventures USA Overview Catalent and Nanoscope Therapeutics have expanded their partnership to support the late-stage development and commercial supply of MCO-010, an optogenetic gene therapy candidate for retinal degenerative d... -
STEMCELL Technologies and CCRM Partner to Accelerate Cell Therapy Development by Expanding Access to Matched GMP/RUO iPSC Lines
Business Wire USA Overview STEMCELL Technologies and the Centre for Commercialization of Regenerative Medicine (CCRM) have announced a strategic partnership to expand access to high-quality human iPSC starting materials. This collaborati... -
Kincell Bio Accelerates Cell Therapy Programs from Clinical Development to Commercialization with Comprehensive CDMO Services
Kincell Bio (company website) USA Overview Kincell Bio offers comprehensive and reliable Contract Development and Manufacturing Organization (CDMO) services, supporting cell therapy programs from early clinical development through commer... -
MSC-Derived Exosomes Emerge as Promising Cell-Free Regenerative Therapies, Driving Active Research in Arthritis, Chronic Wounds, and Inflammatory Diseases
Vertex AI Search USA Overview Mesenchymal Stem Cell (MSC)-derived exosomes are garnering significant attention in regenerative medicine as a cell-free therapeutic alternative, capable of delivering MSCs' potent regenerative and immunomod... -
Continuous Manufacturing and Automated Closed Systems Revolutionize Cell & Gene Therapy Production for Enhanced Efficiency and Quality
News-Medical.net UK Overview The commercial manufacturing of cell and gene therapies is being transformed by the imperative for continuous processing and automated closed systems to overcome current scalability and quality challenges. Th... -
Sartorius and LFB BIOMANUFACTURING Broaden Partnership to Offer Integrated Cell Line Development-to-GMP Services
PharmaSource Global Overview Sartorius and LFB BIOMANUFACTURING have expanded their strategic collaboration to provide integrated services spanning cell line development to GMP drug substance manufacturing. This partnership aims to simpl... -
Minaris Expands GMP Cell Banking Capabilities in Philadelphia, Enhancing Cell & Gene Therapy CDMO Services
Contract Pharma USA Overview Minaris has significantly enhanced its GMP cell banking suite at its Philadelphia facility, expanding its cell and gene therapy (CGT) CDMO services. This upgrade enables comprehensive support for clinical and... -
Tacit Knowledge Loss in Cell & Gene Therapy Tech Transfer Poses Critical Threat to Manufacturing Yield and Quality
Drug Discovery and Development USA Overview The transfer of cell and gene therapy manufacturing processes is severely hampered by the loss of tacit knowledge, impacting product yield and quality. Manual steps in CAR-T cell production, su...
